Clinical Trials: Introduction
Winship Cancer Institute is dedicated to educating cancer patients and their families about standard cancer treatments and new treatments that are available. A cancer clinical trial is an important option to consider when deciding a course of action.
Cancer clinical trials are research studies that test new treatments to find better ways to treat cancer. There are three types of clinical trials.
Phase I Clinical Trial:
A Phase I trial tests a brand new drug, device or procedure. This type of trial does not look for the medical benefits; it only looks for how well humans handle the new drug or procedure. Phase I trials are run to see which dose, or how much of the drug works best.
Learn about the new Phase I Clinical Trial Unit.
Phase II Clinical Trial:
Phase II trials test the drug to see if it works against a specific disease (like prostate cancer). In these research studies, the researchers record the medical benefits they find.
Phase III Clinical Trial:
In Phase III trials, the new drug or procedure is compared to accepted standard treatment to find out which works best.
In 2013, 760 patients were enrolled in 250 Winship clinical trials, testing new therapies. In the last seven years, 75-percent of new cancer treatments approved by the Food and Drug Administration have been tested in clinical trials available at Winship.
Director of Phase I Clinical Trials, Donal Harvey, PharmD, describes the various phases of clinical trials and outlines the program at Winship Cancer Institute in this video:
A Patient's Story
Learning from the experiences of cancer patients is invaluable to healthy individuals, current patients and long-term survivors. CancerQuest (www.cancerquest.org), an educational website produced by Winship Cancer Institute and Emory faculty and staff, presents interviews with cancer patients.